Home / All Categories / Medical Care / Global Neuroendocrine Tumor Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
Global Neuroendocrine Tumor Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
Global Neuroendocrine Tumor Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Pages: 105      Published Date: Aug 2019       Category: Medical Care
Scope of the Report:
The global Neuroendocrine Tumor Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Neuroendocrine Tumor Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Neuroendocrine Tumor Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Neuroendocrine Tumor Treatment market by product type and applications/end industries.

Market Segment by Companies, this report covers
    Progenics Pharmaceuticals, Inc.
    Tarveda Therapeutics
    Hutchinson Medipharma Limited
    Advanced Accelerator Applications
    Exelixis, Inc.
    Dauntless Pharmaceuticals, Inc.
    Novartis AG
    Ispen

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
    Everolimus
    Sunitinib
    Lu-Dotatate
    Lanreotide
    Octreotide

Market Segment by Applications, can be divided into
    Hospitals
    Clinic
    Others
Table of Contents

1 Neuroendocrine Tumor Treatment Market Overview
    1.1 Product Overview and Scope of Neuroendocrine Tumor Treatment
    1.2 Classification of Neuroendocrine Tumor Treatment by Types
        1.2.1 Global Neuroendocrine Tumor Treatment Revenue Comparison by Types (2019-2024)
        1.2.2 Global Neuroendocrine Tumor Treatment Revenue Market Share by Types in 2018
        1.2.3 Everolimus
        1.2.4 Sunitinib
        1.2.5 Lu-Dotatate
        1.2.6 Lanreotide
        1.2.7 Octreotide
    1.3 Global Neuroendocrine Tumor Treatment Market by Application
        1.3.1 Global Neuroendocrine Tumor Treatment Market Size and Market Share Comparison by Applications (2014-2024)
        1.3.2 Hospitals
        1.3.3 Clinic
        1.3.4 Others
    1.4 Global Neuroendocrine Tumor Treatment Market by Regions
        1.4.1 Global Neuroendocrine Tumor Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
        1.4.1 North America (USA, Canada and Mexico) Neuroendocrine Tumor Treatment Status and Prospect (2014-2024)
        1.4.2 Europe (Germany, France, UK, Russia and Italy) Neuroendocrine Tumor Treatment Status and Prospect (2014-2024)
        1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Neuroendocrine Tumor Treatment Status and Prospect (2014-2024)
        1.4.4 South America (Brazil, Argentina, Colombia) Neuroendocrine Tumor Treatment Status and Prospect (2014-2024)
        1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Neuroendocrine Tumor Treatment Status and Prospect (2014-2024)
    1.5 Global Market Size of Neuroendocrine Tumor Treatment (2014-2024)
2 Company Profiles
    2.1 Progenics Pharmaceuticals, Inc.
        2.1.1 Business Overview
        2.1.2 Neuroendocrine Tumor Treatment Type and Applications
            2.1.2.1 Product A
            2.1.2.2 Product B
        2.1.3 Progenics Pharmaceuticals, Inc. Neuroendocrine Tumor Treatment Revenue, Gross Margin and Market Share (2017-2018)
    2.2 Tarveda Therapeutics
        2.2.1 Business Overview
        2.2.2 Neuroendocrine Tumor Treatment Type and Applications
            2.2.2.1 Product A
            2.2.2.2 Product B
        2.2.3 Tarveda Therapeutics Neuroendocrine Tumor Treatment Revenue, Gross Margin and Market Share (2017-2018)
    2.3 Hutchinson Medipharma Limited
        2.3.1 Business Overview
        2.3.2 Neuroendocrine Tumor Treatment Type and Applications
            2.3.2.1 Product A
            2.3.2.2 Product B
        2.3.3 Hutchinson Medipharma Limited Neuroendocrine Tumor Treatment Revenue, Gross Margin and Market Share (2017-2018)
    2.4 Advanced Accelerator Applications
        2.4.1 Business Overview
        2.4.2 Neuroendocrine Tumor Treatment Type and Applications
            2.4.2.1 Product A
            2.4.2.2 Product B
        2.4.3 Advanced Accelerator Applications Neuroendocrine Tumor Treatment Revenue, Gross Margin and Market Share (2017-2018)
    2.5 Exelixis, Inc.
        2.5.1 Business Overview
        2.5.2 Neuroendocrine Tumor Treatment Type and Applications
            2.5.2.1 Product A
            2.5.2.2 Product B
        2.5.3 Exelixis, Inc. Neuroendocrine Tumor Treatment Revenue, Gross Margin and Market Share (2017-2018)
    2.6 Dauntless Pharmaceuticals, Inc.
        2.6.1 Business Overview
        2.6.2 Neuroendocrine Tumor Treatment Type and Applications
            2.6.2.1 Product A
            2.6.2.2 Product B
        2.6.3 Dauntless Pharmaceuticals, Inc. Neuroendocrine Tumor Treatment Revenue, Gross Margin and Market Share (2017-2018)
    2.7 Novartis AG
        2.7.1 Business Overview
        2.7.2 Neuroendocrine Tumor Treatment Type and Applications
            2.7.2.1 Product A
            2.7.2.2 Product B
        2.7.3 Novartis AG Neuroendocrine Tumor Treatment Revenue, Gross Margin and Market Share (2017-2018)
    2.8 Ispen
        2.8.1 Business Overview
        2.8.2 Neuroendocrine Tumor Treatment Type and Applications
            2.8.2.1 Product A
            2.8.2.2 Product B
        2.8.3 Ispen Neuroendocrine Tumor Treatment Revenue, Gross Margin and Market Share (2017-2018)
3 Global Neuroendocrine Tumor Treatment Market Competition, by Players
    3.1 Global Neuroendocrine Tumor Treatment Revenue and Share by Players (2014-2019)
    3.2 Market Concentration Rate
        3.2.1 Top 5 Neuroendocrine Tumor Treatment Players Market Share
        3.2.2 Top 10 Neuroendocrine Tumor Treatment Players Market Share
    3.3 Market Competition Trend
4 Global Neuroendocrine Tumor Treatment Market Size by Regions
    4.1 Global Neuroendocrine Tumor Treatment Revenue and Market Share by Regions
    4.2 North America Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
    4.3 Europe Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
    4.4 Asia-Pacific Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
    4.5 South America Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
    4.6 Middle East and Africa Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
5 North America Neuroendocrine Tumor Treatment Revenue by Countries
    5.1 North America Neuroendocrine Tumor Treatment Revenue by Countries (2014-2019)
    5.2 USA Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
    5.3 Canada Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
    5.4 Mexico Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
6 Europe Neuroendocrine Tumor Treatment Revenue by Countries
    6.1 Europe Neuroendocrine Tumor Treatment Revenue by Countries (2014-2019)
    6.2 Germany Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
    6.3 UK Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
    6.4 France Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
    6.5 Russia Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
    6.6 Italy Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Neuroendocrine Tumor Treatment Revenue by Countries
    7.1 Asia-Pacific Neuroendocrine Tumor Treatment Revenue by Countries (2014-2019)
    7.2 China Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
    7.3 Japan Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
    7.4 Korea Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
    7.5 India Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
    7.6 Southeast Asia Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
8 South America Neuroendocrine Tumor Treatment Revenue by Countries
    8.1 South America Neuroendocrine Tumor Treatment Revenue by Countries (2014-2019)
    8.2 Brazil Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
    8.3 Argentina Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
    8.4 Colombia Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Neuroendocrine Tumor Treatment by Countries
    9.1 Middle East and Africa Neuroendocrine Tumor Treatment Revenue by Countries (2014-2019)
    9.2 Saudi Arabia Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
    9.3 UAE Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
    9.4 Egypt Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
    9.5 Nigeria Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
    9.6 South Africa Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
10 Global Neuroendocrine Tumor Treatment Market Segment by Type
    10.1 Global Neuroendocrine Tumor Treatment Revenue and Market Share by Type (2014-2019)
    10.2 Global Neuroendocrine Tumor Treatment Market Forecast by Type (2019-2024)
    10.3 Everolimus Revenue Growth Rate (2014-2024)
    10.4 Sunitinib Revenue Growth Rate (2014-2024)
    10.5 Lu-Dotatate Revenue Growth Rate (2014-2024)
    10.6 Lanreotide Revenue Growth Rate (2014-2024)
    10.7 Octreotide Revenue Growth Rate (2014-2024)
11 Global Neuroendocrine Tumor Treatment Market Segment by Application
    11.1 Global Neuroendocrine Tumor Treatment Revenue Market Share by Application (2014-2019)
    11.2 Neuroendocrine Tumor Treatment Market Forecast by Application (2019-2024)
    11.3 Hospitals Revenue Growth (2014-2019)
    11.4 Clinic Revenue Growth (2014-2019)
    11.5 Others Revenue Growth (2014-2019)
12 Global Neuroendocrine Tumor Treatment Market Size Forecast (2019-2024)
    12.1 Global Neuroendocrine Tumor Treatment Market Size Forecast (2019-2024)
    12.2 Global Neuroendocrine Tumor Treatment Market Forecast by Regions (2019-2024)
    12.3 North America Neuroendocrine Tumor Treatment Revenue Market Forecast (2019-2024)
    12.4 Europe Neuroendocrine Tumor Treatment Revenue Market Forecast (2019-2024)
    12.5 Asia-Pacific Neuroendocrine Tumor Treatment Revenue Market Forecast (2019-2024)
    12.6 South America Neuroendocrine Tumor Treatment Revenue Market Forecast (2019-2024)
    12.7 Middle East and Africa Neuroendocrine Tumor Treatment Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
    14.1 Methodology
    14.2 Data Source
List of Tables and Figures

Figure Neuroendocrine Tumor Treatment Picture
Table Product Specifications of Neuroendocrine Tumor Treatment
Table Global Neuroendocrine Tumor Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Neuroendocrine Tumor Treatment Revenue Market Share by Types in 2018
Figure Everolimus Picture
Figure Sunitinib Picture
Figure Lu-Dotatate Picture
Figure Lanreotide Picture
Figure Octreotide Picture
Table Global Neuroendocrine Tumor Treatment Revenue (Million USD) by Application (2014-2024)
Figure Neuroendocrine Tumor Treatment Revenue Market Share by Applications in 2018
Figure Hospitals Picture
Figure Clinic Picture
Figure Others Picture
Table Global Market Neuroendocrine Tumor Treatment Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Neuroendocrine Tumor Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Neuroendocrine Tumor Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Neuroendocrine Tumor Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Neuroendocrine Tumor Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Neuroendocrine Tumor Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Neuroendocrine Tumor Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Table Progenics Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table Progenics Pharmaceuticals, Inc. Neuroendocrine Tumor Treatment Type and Applications
Table Progenics Pharmaceuticals, Inc. Neuroendocrine Tumor Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Tarveda Therapeutics Basic Information, Manufacturing Base and Competitors
Table Tarveda Therapeutics Neuroendocrine Tumor Treatment Type and Applications
Table Tarveda Therapeutics Neuroendocrine Tumor Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Hutchinson Medipharma Limited Basic Information, Manufacturing Base and Competitors
Table Hutchinson Medipharma Limited Neuroendocrine Tumor Treatment Type and Applications
Table Hutchinson Medipharma Limited Neuroendocrine Tumor Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Advanced Accelerator Applications Basic Information, Manufacturing Base and Competitors
Table Advanced Accelerator Applications Neuroendocrine Tumor Treatment Type and Applications
Table Advanced Accelerator Applications Neuroendocrine Tumor Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Exelixis, Inc. Basic Information, Manufacturing Base and Competitors
Table Exelixis, Inc. Neuroendocrine Tumor Treatment Type and Applications
Table Exelixis, Inc. Neuroendocrine Tumor Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Dauntless Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table Dauntless Pharmaceuticals, Inc. Neuroendocrine Tumor Treatment Type and Applications
Table Dauntless Pharmaceuticals, Inc. Neuroendocrine Tumor Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis AG Basic Information, Manufacturing Base and Competitors
Table Novartis AG Neuroendocrine Tumor Treatment Type and Applications
Table Novartis AG Neuroendocrine Tumor Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Ispen Basic Information, Manufacturing Base and Competitors
Table Ispen Neuroendocrine Tumor Treatment Type and Applications
Table Ispen Neuroendocrine Tumor Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Global Neuroendocrine Tumor Treatment Revenue (Million USD) by Players (2014-2019)
Table Global Neuroendocrine Tumor Treatment Revenue Share by Players (2014-2019)
Figure Global Neuroendocrine Tumor Treatment Revenue Share by Players in 2017
Figure Global Neuroendocrine Tumor Treatment Revenue Share by Players in 2018
Figure Global Top 5 Players Neuroendocrine Tumor Treatment Revenue Market Share in 2018
Figure Global Top 10 Players Neuroendocrine Tumor Treatment Revenue Market Share in 2018
Figure Global Neuroendocrine Tumor Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Neuroendocrine Tumor Treatment Revenue (Million USD) by Regions (2014-2019)
Table Global Neuroendocrine Tumor Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Neuroendocrine Tumor Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Neuroendocrine Tumor Treatment Revenue Market Share by Regions in 2018
Figure North America Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Figure Europe Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Figure South America Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Table North America Neuroendocrine Tumor Treatment Revenue by Countries (2014-2019)
Table North America Neuroendocrine Tumor Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Neuroendocrine Tumor Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Neuroendocrine Tumor Treatment Revenue Market Share by Countries in 2018
Figure USA Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Figure Canada Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Figure Mexico Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Table Europe Neuroendocrine Tumor Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Europe Neuroendocrine Tumor Treatment Revenue Market Share by Countries (2014-2019)
Figure Europe Neuroendocrine Tumor Treatment Revenue Market Share by Countries in 2018
Figure Germany Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Figure UK Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Figure France Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Figure Russia Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Figure Italy Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Neuroendocrine Tumor Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Neuroendocrine Tumor Treatment Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Neuroendocrine Tumor Treatment Revenue Market Share by Countries in 2018
Figure China Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Figure Japan Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Figure Korea Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Figure India Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Table South America Neuroendocrine Tumor Treatment Revenue by Countries (2014-2019)
Table South America Neuroendocrine Tumor Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Neuroendocrine Tumor Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Neuroendocrine Tumor Treatment Revenue Market Share by Countries in 2018
Figure Brazil Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Figure Argentina Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Figure Colombia Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Neuroendocrine Tumor Treatment Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Neuroendocrine Tumor Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Neuroendocrine Tumor Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Neuroendocrine Tumor Treatment Revenue Market Share by Countries in 2018
Figure Saudi Arabia Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Figure UAE Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Figure Egypt Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Figure Nigeria Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Figure South Africa Neuroendocrine Tumor Treatment Revenue and Growth Rate (2014-2019)
Table Global Neuroendocrine Tumor Treatment Revenue (Million USD) by Type (2014-2019)
Table Global Neuroendocrine Tumor Treatment Revenue Share by Type (2014-2019)
Figure Global Neuroendocrine Tumor Treatment Revenue Share by Type (2014-2019)
Figure Global Neuroendocrine Tumor Treatment Revenue Share by Type in 2018
Table Global Neuroendocrine Tumor Treatment Revenue Forecast by Type (2019-2024)
Figure Global Neuroendocrine Tumor Treatment Market Share Forecast by Type (2019-2024)
Figure Global Everolimus Revenue Growth Rate (2014-2019)
Figure Global Sunitinib Revenue Growth Rate (2014-2019)
Figure Global Lu-Dotatate Revenue Growth Rate (2014-2019)
Figure Global Lanreotide Revenue Growth Rate (2014-2019)
Figure Global Octreotide Revenue Growth Rate (2014-2019)
Table Global Neuroendocrine Tumor Treatment Revenue by Application (2014-2019)
Table Global Neuroendocrine Tumor Treatment Revenue Share by Application (2014-2019)
Figure Global Neuroendocrine Tumor Treatment Revenue Share by Application (2014-2019)
Figure Global Neuroendocrine Tumor Treatment Revenue Share by Application in 2018
Table Global Neuroendocrine Tumor Treatment Revenue Forecast by Application (2019-2024)
Figure Global Neuroendocrine Tumor Treatment Market Share Forecast by Application (2019-2024)
Figure Global Hospitals Revenue Growth Rate (2014-2019)
Figure Global Clinic Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Neuroendocrine Tumor Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Neuroendocrine Tumor Treatment Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Neuroendocrine Tumor Treatment Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Neuroendocrine Tumor Treatment Revenue Market Forecast (2019-2024)
Figure Europe Neuroendocrine Tumor Treatment Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Neuroendocrine Tumor Treatment Revenue Market Forecast (2019-2024)
Figure South America Neuroendocrine Tumor Treatment Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Neuroendocrine Tumor Treatment Revenue Market Forecast (2019-2024)
Progenics Pharmaceuticals, Inc.
    Tarveda Therapeutics
    Hutchinson Medipharma Limited
    Advanced Accelerator Applications
    Exelixis, Inc.
    Dauntless Pharmaceuticals, Inc.
    Novartis AG
    Ispen
Request sample
If you need any reports sample, just let us know
Request message: *
Your Name: *
Email Address: *
Country:
Phone Number:
Verification code: *
 
We aim to respond to all request on the same business day.

Purchase this Market Research Report

Single User License $3,480.00
Multi User License $5,220.00
Corporate Users License $6,960.00
Add to Cart Buy Now
goods_purchanse_ico goods_purchanse_ico goods_purchanse_ico goods_purchanse_ico goods_purchanse_ico